CMS Implements Nationwide Moratorium on New DMEPOS Suppliers

On February 27, 2026, the Centers for Medicare & Medicaid Services (CMS) implemented a temporary nationwide moratorium on new Medicare enrollments for certain durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) suppliers. The moratorium does not impact existing enrolled DMEPOS suppliers. The moratorium is intended to address ongoing concerns about fraudulent billing and program abuse within the DME sector. The moratorium will remain in effect for 6 months and CMS may extend the moratorium in 6 month increments if CMS determines it is necessary to do so. During the moratorium period, CMS will pause approval of new supplier enrollments while it strengthens oversight and monitoring efforts aimed at preventing improper payments and protecting the integrity of the Medicare program. Each individual state will determine whether a form of the DMEPOS moratorium is appropriate for their respective Medicaid and CHIP programs. Further, CMS is soliciting input from stakeholders on additional ways CMS can prevent fraud under CMS’s Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH) initiative.